What are treatment options for recurrent lung cancer?
Community Member
13 days ago4 years ago I was diagnosed with lung NSCLC. They removed my right lower lobe of my lung. 2years later in came back and the Drs. Recommended CyberKnife treatments. Had that and a year later due to scar tissue from that treatment my upper lobe has collapsed. Present it has returned again in the middle lobe. I just had a needle biopsy and blood draw for BioMarkers. Two weeks and the results are still not finalized. Waiting for results so I can start treatments. What are some of the treatments like with side effects.
Community Member
13 days agoTreatment options for recurrent lung cancer can vary significantly based on specific biomarker results and individual circumstances, which is why waiting for those test results is such an important step in determining the best path forward. Common approaches may include targeted therapies, immunotherapy, chemotherapy, or additional radiation treatments, each with different side effect profiles ranging from fatigue and nausea to more specific effects depending on the treatment type. The medical team will be able to discuss the most suitable options and their potential side effects once the biomarker results are available, helping to create a personalized treatment plan that considers the previous treatments and current situation.
New to the community?
Create an account to connect with others navigating cancer.
Related Questions
- How do I cope when cancer is stable but still there after radiation?
- Should I Wait for Clinical Study Results or Start Cancer Treatment Immediately?
- Should I ask for liquid biopsy if lung cancer seems to be progressing?
- Why isn't my lung cancer tumor shrinking after treatment?
- How to Cope with Multiple Lung Cancer Diagnoses?
- What are my options when lung cancer spreads and radiation stops working?
- How does my EGFR mutation affect lung cancer treatment?
- How can I manage Tagrisso side effects like rash and diarrhea?
© 2026 Outcomes4Me Inc. All rights reserved.